CD1A and psoriasis: We and others have previously shown that patients with psoriasis exhibit aberrant release of type 22 and 17 related cytokines upon pan-T stimuli (Figure S3) (55), as well as elevated circulating and cutaneous CD1a-reactive T cells (29, 32), but there have been no studies which have addressed the relevance of GAS in the CD1a pathway in patients.